|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9155
|
|
pubmed:dateCreated |
1999-8-31
|
|
pubmed:abstractText |
Resection of hepatocellular carcinoma is potentially curative, but local recurrence is common. In this prospective randomised trial, we aimed to find out if one dose of postoperative adjuvant intra-arterial iodine-131-labelled lipiodol could reduce the rate of local recurrence and increase disease-free and overall survival.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0140-6736
|
|
pubmed:author |
pubmed-author:ChanA TAT,
pubmed-author:ChanMM,
pubmed-author:DaiJ XJX,
pubmed-author:INS ISI,
pubmed-author:JohnsonP JPJ,
pubmed-author:LawHH,
pubmed-author:LeeW EWE,
pubmed-author:LeungN WNW,
pubmed-author:LeungT WTW,
pubmed-author:MachinDD,
pubmed-author:YepPP,
pubmed-author:YuS CSC
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
6
|
|
pubmed:volume |
353
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
797-801
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10459961-Adolescent,
pubmed-meshheading:10459961-Adult,
pubmed-meshheading:10459961-Aged,
pubmed-meshheading:10459961-Carcinoma, Hepatocellular,
pubmed-meshheading:10459961-Disease-Free Survival,
pubmed-meshheading:10459961-Female,
pubmed-meshheading:10459961-Humans,
pubmed-meshheading:10459961-Injections, Intra-Arterial,
pubmed-meshheading:10459961-Iodine Radioisotopes,
pubmed-meshheading:10459961-Iodized Oil,
pubmed-meshheading:10459961-Lung Neoplasms,
pubmed-meshheading:10459961-Male,
pubmed-meshheading:10459961-Middle Aged,
pubmed-meshheading:10459961-Neoplasm Recurrence, Local,
pubmed-meshheading:10459961-Prospective Studies,
pubmed-meshheading:10459961-Radiotherapy, Adjuvant,
pubmed-meshheading:10459961-Survivors
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial.
|
|
pubmed:affiliation |
Department of Surgery, and Centre for Clinical Trials and Epidemiological Research, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
